RUSSO, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 8.260
EU - Europa 7.633
AS - Asia 4.122
SA - Sud America 1.387
Continente sconosciuto - Info sul continente non disponibili 427
AF - Africa 125
OC - Oceania 8
Totale 21.962
Nazione #
US - Stati Uniti d'America 8.005
RU - Federazione Russa 3.856
SG - Singapore 1.705
BR - Brasile 1.185
CN - Cina 1.172
IE - Irlanda 916
SE - Svezia 805
IT - Italia 525
HK - Hong Kong 480
DE - Germania 335
FR - Francia 266
VN - Vietnam 226
PL - Polonia 214
UA - Ucraina 208
GB - Regno Unito 174
FI - Finlandia 155
IN - India 110
CA - Canada 93
AR - Argentina 67
MX - Messico 67
BD - Bangladesh 65
IQ - Iraq 53
ID - Indonesia 46
EC - Ecuador 40
TR - Turchia 39
ZA - Sudafrica 38
AT - Austria 34
BE - Belgio 33
JP - Giappone 33
CO - Colombia 28
ES - Italia 28
VE - Venezuela 24
NL - Olanda 23
UZ - Uzbekistan 23
CR - Costa Rica 17
KE - Kenya 17
PK - Pakistan 17
AZ - Azerbaigian 16
MA - Marocco 16
MY - Malesia 16
CL - Cile 15
JM - Giamaica 14
JO - Giordania 13
HN - Honduras 12
PH - Filippine 12
TN - Tunisia 12
IL - Israele 11
SA - Arabia Saudita 11
NP - Nepal 10
UY - Uruguay 10
CI - Costa d'Avorio 9
IR - Iran 9
LV - Lettonia 9
DZ - Algeria 8
KZ - Kazakistan 8
PY - Paraguay 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
AL - Albania 7
DO - Repubblica Dominicana 7
AU - Australia 6
GT - Guatemala 6
PE - Perù 6
RO - Romania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
GP - Guadalupe 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
BY - Bielorussia 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
PS - Palestinian Territory 4
PT - Portogallo 4
TW - Taiwan 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
LB - Libano 3
LT - Lituania 3
NG - Nigeria 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
GD - Grenada 2
GE - Georgia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
Totale 21.511
Città #
Ashburn 1.341
Moscow 1.120
Singapore 967
Dublin 913
Chandler 674
Dallas 531
Hong Kong 476
San Jose 459
Jacksonville 420
Beijing 402
Nyköping 383
Council Bluffs 310
Warsaw 210
Los Angeles 183
The Dalles 170
Princeton 167
Lauterbourg 142
Medford 142
Messina 134
Cambridge 130
Dearborn 127
Des Moines 121
Ann Arbor 110
São Paulo 98
New York 88
Boardman 73
Munich 72
Santa Clara 71
Buffalo 68
Ho Chi Minh City 67
San Mateo 55
Bremen 54
Jinan 52
Redondo Beach 52
Tianjin 52
Wilmington 50
Shenyang 46
Hanoi 43
Guangzhou 36
Belo Horizonte 35
Woodbridge 33
Atlanta 32
Houston 32
Rio de Janeiro 32
Brussels 31
Frankfurt am Main 31
Tokyo 31
Nuremberg 30
Phoenix 30
Turku 30
Montreal 29
Chicago 28
Orem 28
Seattle 28
Brooklyn 27
Catania 27
Rome 27
Brasília 26
North Bergen 25
Pune 25
Baghdad 24
Jakarta 24
Nanjing 23
Columbus 22
Dong Ket 22
Hebei 22
Tashkent 22
Curitiba 21
Denver 21
Haikou 21
Milan 21
Mexico City 20
London 19
Campinas 17
Johannesburg 16
Mumbai 16
Nairobi 16
Porto Alegre 16
San Francisco 16
Shanghai 16
Baku 15
Quito 15
Vienna 15
Amsterdam 14
Charlotte 14
Falls Church 14
Lancaster 14
Lawrenceville 14
Naples 14
Poplar 14
San José 14
Zhengzhou 14
Boston 13
Chennai 13
Istanbul 13
Ningbo 13
Shenzhen 13
Stockholm 13
Washington 13
Amman 12
Totale 11.895
Nome #
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 290
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 262
Ischemic stroke and reperfusion therapies in diabetic patients 257
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 239
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 224
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 206
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 204
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 201
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 201
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 201
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 200
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes. 200
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 199
Pimozide and pancreatic cancer in diabetic chorea: a case report 195
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 195
.Frequence of FDB in a hypercholesterolemic population from east Sicily 193
Multiple osteoporotic fractures complicating Wolfram syndrome 193
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 190
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 182
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 181
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 181
Elevata prevalenza della colonizzazione da parte di Arcobacter spp. in soggetti asintomatici con diabete di tipo 2 175
Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus. 174
Correlates of total homocysteine plasma concentration in type 2 diabetes 169
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach. 169
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 168
Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene with Bone Phenotypes Depends on Plasma Folate Status 165
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 162
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 161
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 160
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 160
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 160
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 159
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 158
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 158
Genomic Variations Affecting Biological Effects of Statins 157
Artificial intelligence and big data in diabetes care: A position statement of the Italian association of medical diabetologists 157
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 156
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 154
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 153
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 153
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 151
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 151
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 149
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 148
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 147
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 147
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 147
Livelli plasmatici di resistina e proteina C- reattiva nelle donne: ruolo del diabete di tipo 2 e della menopausa. 145
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 145
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 145
Analoghi del Glucagon-like peptide-1: cosa ci riserva il futuro. 144
3. High-density lipoprotein as a coronary heart disease risk factor and gene mutations affecting high-density lipoprotein cholesterol levels: Results from the Framingham Heart Study 143
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 142
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 142
Atherogenic dyslipidemia and diabetic nephropathy 142
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 140
Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus 140
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 139
Type 2 diabetes and cardiovascular risk in women. 138
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 136
Gli Standard di Cura terzo step: incretina + metformina. 136
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 131
ELEVATA PREVALENZA DELLA COLONIZZAZIONE DA PARTE DI ARCOBACTER P: IN SOGGETTI ASINTOMATICI CON DIABETE DI TIPO 2. 130
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. 130
Diabetic kidney disease in the elderly: Prevalence and clinical correlates 130
Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now? 129
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 126
Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database. 126
Livelli di resistina nelle donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 125
Necrobiosis lipoidica associated with Hashimoto's thyroiditis and positive detection of ANA and ASMA autoantibodies 124
CAPTURE: a multinational,cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. 124
Inflammatory markers in women with a recent history of gestational diabetes mellitus 123
A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: the amd annals initiative 122
IPEROMOCISTEINEMIA E RISCHIO CARDIOVASCOLARE NEL DIABETE: FANTASIA O REALTA'? 122
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 122
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus 121
Livelli di omocisteina, vitamina B12 e folati in soggetti con diabete mellito di tipo 2 con o senza neuropatia diabetica. Ruolo della metformina 121
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 121
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 120
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 120
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 119
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 119
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 118
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 118
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study. 118
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 116
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. 115
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 114
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes 113
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 113
Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study 113
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. 112
POLIMORFISMO DEL GENE DELL'APOLIPOPROTEINA E E PATOLOGIA COLELITIASICA IN UNA POPOLAZIONE DEL SUD ITALIA 111
GLP-1 Receptor Agonists and Kidney Protection 108
determinants of total homocysteine plasma levels in type 2 diabetes 108
Ruolo dell’ipercisteinemia e del genotipo C677T del gene della metilene tetraidrifolato redattasi (MTHFR) in una popolazione di diabetici di tipo 2 con e senza Sindrome Metabolica 107
Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: A real-life observational study 107
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 106
Frequence of FDP in a hypercholesterolemic population from East Sicily 105
Totale 15.146
Categoria #
all - tutte 77.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 0 0 46 34 10 88 41 25 276 123 346
2022/20232.655 193 195 137 214 205 251 25 174 1.151 19 62 29
2023/2024608 47 90 44 56 42 134 19 42 3 27 18 86
2024/20253.329 50 52 73 207 168 125 84 653 822 201 303 591
2025/20269.401 425 564 666 651 806 1.991 1.225 1.122 1.160 425 173 193
2026/20272.201 216 665 545 775 0 0 0 0 0 0 0 0
Totale 21.962